Report Detail
Global Benign Prostatic Hyperplasic Device Market Growth 2022-2028
- RnM4473956 |
- 27 July, 2022 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
The global market for Benign Prostatic Hyperplasic Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Benign Prostatic Hyperplasic Device players cover KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix and Boston Scientific Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Benign Prostatic Hyperplasic Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Benign Prostatic Hyperplasic Device market, with both quantitative and qualitative data, to help readers understand how the Benign Prostatic Hyperplasic Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Benign Prostatic Hyperplasic Device market and forecasts the market size by Type (Radiofrequency Ablation Devices, Urology Lasers Devices and Others), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Radiofrequency Ablation Devices
Urology Lasers Devices
Others
Segmentation by application
Hospitals
Clinics
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
KARL STORZ SE
Richard Wolf GmbH
Olympus Corporation
Urologix
Boston Scientific Corporation
Butterfly
TELEFLEX Incorporated
OmniGuide Holdings
Convergent Laser Technologies
ProArc
Olympus Corporation
Chapter Introduction
Chapter 1: Scope of Benign Prostatic Hyperplasic Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Benign Prostatic Hyperplasic Device market size (sales and revenue) and CAGR, Benign Prostatic Hyperplasic Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Benign Prostatic Hyperplasic Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Benign Prostatic Hyperplasic Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Benign Prostatic Hyperplasic Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix, Boston Scientific Corporation, Butterfly, TELEFLEX Incorporated, OmniGuide Holdings and Convergent Laser Technologies, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasic Device by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasic Device by Country/Region, 2017, 2022 & 2028
- 2.2 Benign Prostatic Hyperplasic Device Segment by Type
- 2.2.1 Radiofrequency Ablation Devices
- 2.2.2 Urology Lasers Devices
- 2.2.3 Others
- 2.3 Benign Prostatic Hyperplasic Device Sales by Type
- 2.3.1 Global Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
- 2.3.2 Global Benign Prostatic Hyperplasic Device Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Benign Prostatic Hyperplasic Device Sale Price by Type (2017-2022)
- 2.4 Benign Prostatic Hyperplasic Device Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Benign Prostatic Hyperplasic Device Sales by Application
- 2.5.1 Global Benign Prostatic Hyperplasic Device Sale Market Share by Application (2017-2022)
- 2.5.2 Global Benign Prostatic Hyperplasic Device Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Benign Prostatic Hyperplasic Device Sale Price by Application (2017-2022)
3 Global Benign Prostatic Hyperplasic Device by Company
- 3.1 Global Benign Prostatic Hyperplasic Device Breakdown Data by Company
- 3.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Company (2020-2022)
- 3.1.2 Global Benign Prostatic Hyperplasic Device Sales Market Share by Company (2020-2022)
- 3.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Company (2020-2022)
- 3.2.1 Global Benign Prostatic Hyperplasic Device Revenue by Company (2020-2022)
- 3.2.2 Global Benign Prostatic Hyperplasic Device Revenue Market Share by Company (2020-2022)
- 3.3 Global Benign Prostatic Hyperplasic Device Sale Price by Company
- 3.4 Key Manufacturers Benign Prostatic Hyperplasic Device Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Benign Prostatic Hyperplasic Device Product Location Distribution
- 3.4.2 Players Benign Prostatic Hyperplasic Device Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Benign Prostatic Hyperplasic Device by Geographic Region
- 4.1 World Historic Benign Prostatic Hyperplasic Device Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Geographic Region
- 4.2 World Historic Benign Prostatic Hyperplasic Device Market Size by Country/Region (2017-2022)
- 4.2.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Country/Region
- 4.3 Americas Benign Prostatic Hyperplasic Device Sales Growth
- 4.4 APAC Benign Prostatic Hyperplasic Device Sales Growth
- 4.5 Europe Benign Prostatic Hyperplasic Device Sales Growth
- 4.6 Middle East & Africa Benign Prostatic Hyperplasic Device Sales Growth
5 Americas
- 5.1 Americas Benign Prostatic Hyperplasic Device Sales by Country
- 5.1.1 Americas Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
- 5.1.2 Americas Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
- 5.2 Americas Benign Prostatic Hyperplasic Device Sales by Type
- 5.3 Americas Benign Prostatic Hyperplasic Device Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Benign Prostatic Hyperplasic Device Sales by Region
- 6.1.1 APAC Benign Prostatic Hyperplasic Device Sales by Region (2017-2022)
- 6.1.2 APAC Benign Prostatic Hyperplasic Device Revenue by Region (2017-2022)
- 6.2 APAC Benign Prostatic Hyperplasic Device Sales by Type
- 6.3 APAC Benign Prostatic Hyperplasic Device Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Benign Prostatic Hyperplasic Device by Country
- 7.1.1 Europe Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
- 7.1.2 Europe Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
- 7.2 Europe Benign Prostatic Hyperplasic Device Sales by Type
- 7.3 Europe Benign Prostatic Hyperplasic Device Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Benign Prostatic Hyperplasic Device by Country
- 8.1.1 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Type
- 8.3 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasic Device
- 10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasic Device
- 10.4 Industry Chain Structure of Benign Prostatic Hyperplasic Device
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Benign Prostatic Hyperplasic Device Distributors
- 11.3 Benign Prostatic Hyperplasic Device Customer
12 World Forecast Review for Benign Prostatic Hyperplasic Device by Geographic Region
- 12.1 Global Benign Prostatic Hyperplasic Device Market Size Forecast by Region
- 12.1.1 Global Benign Prostatic Hyperplasic Device Forecast by Region (2023-2028)
- 12.1.2 Global Benign Prostatic Hyperplasic Device Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Benign Prostatic Hyperplasic Device Forecast by Type
- 12.7 Global Benign Prostatic Hyperplasic Device Forecast by Application
13 Key Players Analysis
- 13.1 KARL STORZ SE
- 13.1.1 KARL STORZ SE Company Information
- 13.1.2 KARL STORZ SE Benign Prostatic Hyperplasic Device Product Offered
- 13.1.3 KARL STORZ SE Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 KARL STORZ SE Main Business Overview
- 13.1.5 KARL STORZ SE Latest Developments
- 13.2 Richard Wolf GmbH
- 13.2.1 Richard Wolf GmbH Company Information
- 13.2.2 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Offered
- 13.2.3 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Richard Wolf GmbH Main Business Overview
- 13.2.5 Richard Wolf GmbH Latest Developments
- 13.3 Olympus Corporation
- 13.3.1 Olympus Corporation Company Information
- 13.3.2 Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
- 13.3.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Olympus Corporation Main Business Overview
- 13.3.5 Olympus Corporation Latest Developments
- 13.4 Urologix
- 13.4.1 Urologix Company Information
- 13.4.2 Urologix Benign Prostatic Hyperplasic Device Product Offered
- 13.4.3 Urologix Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Urologix Main Business Overview
- 13.4.5 Urologix Latest Developments
- 13.5 Boston Scientific Corporation
- 13.5.1 Boston Scientific Corporation Company Information
- 13.5.2 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Offered
- 13.5.3 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Boston Scientific Corporation Main Business Overview
- 13.5.5 Boston Scientific Corporation Latest Developments
- 13.6 Butterfly
- 13.6.1 Butterfly Company Information
- 13.6.2 Butterfly Benign Prostatic Hyperplasic Device Product Offered
- 13.6.3 Butterfly Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Butterfly Main Business Overview
- 13.6.5 Butterfly Latest Developments
- 13.7 TELEFLEX Incorporated
- 13.7.1 TELEFLEX Incorporated Company Information
- 13.7.2 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Offered
- 13.7.3 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 TELEFLEX Incorporated Main Business Overview
- 13.7.5 TELEFLEX Incorporated Latest Developments
- 13.8 OmniGuide Holdings
- 13.8.1 OmniGuide Holdings Company Information
- 13.8.2 OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Offered
- 13.8.3 OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 OmniGuide Holdings Main Business Overview
- 13.8.5 OmniGuide Holdings Latest Developments
- 13.9 Convergent Laser Technologies
- 13.9.1 Convergent Laser Technologies Company Information
- 13.9.2 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Offered
- 13.9.3 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Convergent Laser Technologies Main Business Overview
- 13.9.5 Convergent Laser Technologies Latest Developments
- 13.10 ProArc
- 13.10.1 ProArc Company Information
- 13.10.2 ProArc Benign Prostatic Hyperplasic Device Product Offered
- 13.10.3 ProArc Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 ProArc Main Business Overview
- 13.10.5 ProArc Latest Developments
- 13.11 Olympus Corporation
- 13.11.1 Olympus Corporation Company Information
- 13.11.2 Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
- 13.11.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Olympus Corporation Main Business Overview
- 13.11.5 Olympus Corporation Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Benign Prostatic Hyperplasic Device. Industry analysis & Market Report on Benign Prostatic Hyperplasic Device is a syndicated market report, published as Global Benign Prostatic Hyperplasic Device Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Benign Prostatic Hyperplasic Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
